
We evaluated the responses of 39 children with cancer who, after failure to respond to conventional zzso agents, received either or both of two zzso zzso zzso zzso and zzso zzso zzso zzso patients has acute zzso leukemia zzso 12 had acute zzso leukemia zzso and ten had solid zzso Initially, the patients in each disease category were zzso to receive 50 zzso of zzso zzso zzso twice weekly or 75 zzso zzso of zzso twice weekly for 4 zzso Drug zzso and schedules of administration were adjusted during the course of the zzso Although objective responses were not detected in the zzso group of solid tumor patients, zzso clinical responses were obtained in nine of the 29 patients with acute zzso The responses to the two zzso were noted in patients with ALL as well as in patients with zzso zzso zzso included zzso zzso zzso fever, zzso zzso and zzso These results, the first reported with both zzso and zzso in childhood cancer, indicate that the zzso are well tolerated and may be effective against acute zzso 

